Data / Drug companies / Guthy-Renker LLC
Guthy-Renker LLC: 9 products in the FDA NDC directory, labeler code 70605
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guthy-Renker LLC (labeler code 70605) lists 9 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 9 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 30, 2026.
The request: Watch Guthy-Renker LLC (FDA labeler code 70605): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 70605
- Products in commercial distribution
- 9
- Packages
- 10
- Finished drugs by generic name
- 8
- Prescription products
- 0
- Over the counter products
- 9
- Flagged as original packager
- 9 of 9 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- April 30, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 9 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 9 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Avobenzone, octinoxate, octisalate, and octocrylene | 1 | 1 |
| Octinoxate, octisalate, and oxybenzone | 1 | 1 |
| Meradimate, octinoxate, oxybenzone, and zinc oxide | 1 | 1 |
| Octinoxate and octisalate | 1 | 2 |
| Sulfur | 1 | 52 |
| Salicylic acid | 1 | 330 |
| Titanium dioxide | 1 | 51 |
| Octinoxate, octisalate, and zinc oxide | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 7 | 77.8% |
| Lotion | 1 | 11.1% |
| Liquid | 1 | 11.1% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Principal Secret Blemish Buster Clear | 70605-021 | Liquid | Over the counter monograph drugs | June 30, 2026 |
| Principal Secret Revolutionary Anti-Aging Broad Spectrum SPF 15 | 70605-020 | Lotion | Over the counter monograph drugs | April 1, 2026 |
| Principal Secret Reclaim Oil Control hydrator SPF-8 | 70605-028 | Cream | Over the counter monograph drugs | December 1, 2023 |
| Blemish Buster Solution Acne Treatment | 70605-018 | Cream | Over the counter monograph drugs | December 31, 2017 |
| Principal Secret Advanced with Hydrospheres Continuous Moisture SPF8 | 70605-017 | Cream | Over the counter monograph drugs | December 31, 2017 |
| Reclaim Revolutionary Anti-Aging Day SPF15 | 70605-042 | Cream | Over the counter monograph drugs | December 30, 2017 |
| Jane Seymour Natural Advantage AM SPF 15 All Day Moisture with AHAs | 70605-026 | Cream | Over the counter monograph drugs | December 30, 2017 |
| Principal Secret Reclaim Botanical (with SP) Radiant Recovery Day Broad Spectrum SPF 15 | 70605-029 | Cream | Over the counter monograph drugs | April 30, 2016 |
| Principal Secret Reclaim Sunscreen For Face and Body SPF 30 | 70605-014 | Cream | Over the counter monograph drugs | April 30, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.